Where does insulin resistance in lipodystrophic HIV-1-positive subjects come from?
Schmidt
H H
HH
D019380:Anti-HIV Agents / Q000009:adverse effects*; D005947:Glucose / Q000378:metabolism; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D015497:HIV-1; D006801:Humans; D007333:Insulin Resistance; D008060:Lipodystrophy / Q000139:chemically induced*; D011480:Protease Inhibitors / Q000009:adverse effects*
D019380:Anti-HIV Agents; D011480:Protease Inhibitors; D005947:Glucose